mBio
(Jun 2021)
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
Najmeh Bozorgmehr,
Siavash Mashhouri,
Eliana Perez Rosero,
Lai Xu,
Shima Shahbaz,
Wendy Sligl,
Mohammed Osman,
Demetrios J. Kutsogiannis,
Erika MacIntyre,
Conar R. O’Neil,
Shokrollah Elahi
Affiliations
Najmeh Bozorgmehr
School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
Siavash Mashhouri
School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
Eliana Perez Rosero
School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
Lai Xu
School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
Shima Shahbaz
School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
Wendy Sligl
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Mohammed Osman
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Demetrios J. Kutsogiannis
Department of Critical Care Medicine, University of Alberta, Edmonton, Alberta, Canada
Erika MacIntyre
Misericordia Community Hospital, Edmonton, Alberta, Canada
Conar R. O’Neil
Division of Infectious Diseases, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
Shokrollah Elahi
ORCiD School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
DOI
https://doi.org/10.1128/mBio.00384-21
Journal volume & issue
Vol. 12,
no. 3
Abstract
Read online
The outbreak of SARS-CoV-2 infection has enormously impacted our lives. Clinical evidence has implicated the emergence of cytokine release syndrome as the prominent cause of mortality in COVID-19 patients.
WeChat QR code
Close
